News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Tycel Jovelle Phillips, MD, University of Michigan

Articles by Tycel Jovelle Phillips, MD, University of Michigan

Lenalidomide and Bortezomib for Mantle Cell Lymphoma

ByJohn P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine,Krish Patel, MD, Swedish Medical Center,Tycel Jovelle Phillips, MD, University of Michigan,Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center

January 26th 2021

Go-To Treatment Regimens in Mantle Cell Lymphoma

ByJohn P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine,Krish Patel, MD, Swedish Medical Center,Tycel Jovelle Phillips, MD, University of Michigan,Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center

January 26th 2021

Treatment Approaches in Mantle Cell Lymphoma

ByJohn P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine,Krish Patel, MD, Swedish Medical Center,Tycel Jovelle Phillips, MD, University of Michigan,Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center

January 19th 2021

Accurately Diagnosing Mantle Cell Lymphoma

ByJohn P. Leonard, MD, New York-Presbyterian/Weill Cornell Medicine,Krish Patel, MD, Swedish Medical Center,Tycel Jovelle Phillips, MD, University of Michigan,Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center

January 19th 2021

Trending on OncLive

Patient-Level Data Show Extended OS Advantage With DCVax-L vs External Controls in Glioblastoma

Zoldonrasib Combinations Show Compelling Antitumor Activity in RAS G12D–Mutant Metastatic PDAC

Hematologists Detail Practice-Shaping Data That Emerged at EHA 2026 (VIDEO)

Data Point to Pirtobrutinib-Based Regimens as a New SOC Option for R/R CLL

Ensartinib Reduces Recurrence Risk After Resection in ALK-Positive NSCLC